Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial.
暂无分享,去创建一个
B. Zinman | C. Wanner | P. Groop | H. Heerspink | S. Inzucchi | U. Broedl | H. Woerle | M. von Eynatten | M. Mattheus | S. Hantel | A. Koitka‐Weber | Audrey Koitka‐Weber